| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $25.66M | $48.22M | $29.46M | $47.31M | $44.94M |
| SG&A | $9.60M | $11.89M | $13.34M | $15.37M | $11.28M |
| Operating Income | -$35.27M | -$60.12M | -$42.79M | -$62.68M | -$56.22M |
| Interest Expense | – | – | $2.07M | $1.69M | $1.74M |
| Tax Expense | $0.00 | $1.00K | $0.00 | $0.00 | $0.00 |
| Net Income | -$33.85M | -$55.85M | -$37.54M | -$62.02M | -$57.78M |
| EPS (basic) | -0.5600 | -0.9400 | -0.6400 | -1.0600 | -1.0700 |
| EPS (diluted) | -0.5600 | -0.9400 | -0.6400 | -1.0600 | -1.0700 |
| Shares (diluted) | $60.06M | $59.48M | $58.94M | $58.41M | $54.04M |